1061 East Indiantown Road
Suite 110
Jupiter, FL 33477
United States
561 244 7100
https://www.jupiterwellness.com
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 12
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Glynn Wilson Ph.D. | Chief Science Officer & Chairman | 121.88k | N/A | 1947 |
Mr. Brian Scott John | Chief Investment Officer, CEO & Exec. Director | 263.12k | N/A | 1969 |
Mr. Richard A. Miller | Sec. | 194.16k | N/A | 1968 |
Mr. Douglas O. McKinnon | Chief Financial Officer | N/A | N/A | 1951 |
Dr. Andy Goren M.D. | Chief Medical Officer & Member of Scientific Advisory Board | N/A | N/A | 1972 |
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Jupiter Wellness, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.